Page 238 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg

Chapter 9
References
1. Van Schaik RHN. Clinical Application of Pharmacogenetics: Where are we now? eJIFCC. 2013;4(3- 4):1-8.
2. DAILYMED. Ziagen - Abacavir sulfate tablet, film coated Drug Label Information [Website]. 2017; https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca73b519-015a-436d-aa3c- af53492825a1. Accessed 05 May 2017.
3. Amur S, Frueh FW, Lesko LJ, Huang SM. Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective. Biomark Med. 2008;2(3):305-311.
4. FDA. List of Human Genetic Tests Nucleic Acid Based Tests [Website]. https://www.fda.gov/ MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm330711.htm. Accessed 05 May 2017.
5. FDA. Recently-Approved Devices. [Website]. https://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ default.htm. Accessed 05 May 2017.
6. Roche. Analysis of CYP2D6 and CYP2C19 genes. [Website]. 2009; https://web.archive.org/ web/20110906084820/http://molecular.roche.com:80/assays/Pages/AmpliChipCYP450Test. aspx. Accessed 05 May 2017.
7. FDA. Laboratory Developed Tests. 2018; https://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/InVitroDiagnostics/LaboratoryDevelopedTests/default.htm.
8. IFCC. Molecular Diagnostics Committee (C-MD). [Website]. 2017; http://www.ifcc.org/ifcc- scientific-division/sd-committees/c-md/. Accessed 05 May 2017.
9. RfB. [Website]. 2017; https://www.rfb.bio/cgi/switchLang?lang=en. Accessed 05 May 2017.
10. EMQN. 2018; https://www.emqn.org/. Accessed 16 Nov 2018.
11. SKML. Dutch Foundation for Quality Assurance of Medical Laboratory Diagnostics. [Website].
2017; https://skml.nl/. Accessed 05 May 2017.
12. Pratt VM, Everts RE, Aggarwal P, et al. Characterization of 137 Genomic DNA Reference Materials
for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project. J Mol Diagn. 2016;18(1):109-
123.
13. PharmGKB. Drug Labels. [Website]. https://www.pharmgkb.org/view/drug-labels.do. Accessed
05 May 2017.
14. McCarthy JJ, McLeod HL, Ginsburg GS. Genomic medicine: a decade of successes, challenges,
and opportunities. Sci Transl Med. 2013;5(189):189sr184.
15. Lunenburg CATC, Henricks LM, Guchelaar HJ, et al. Prospective DPYD genotyping to reduce the
risk of fluoropyrimidine-induced severe toxicity: Ready for prime time. Eur J Cancer. 2016;54:40-
48.
16. Amstutz U, Henricks LM, Offer SM, et al. Clinical Pharmacogenetics Implementation Consortium
(CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing:
2017 Update. Clin Pharmacol Ther. 2018;103(2):210-216.
17. KNMP. Royal Dutch Society for the Advancement of Pharmacy. Fluorouracil/Capecitabine
DPD gene activity score and guidelines. [Website]. 2015; https://kennisbank.knmp.nl/article/ farmacogenetica/2552-4893-4894.html. Accessed 05 May 2017.
236